Correction to: Efficacy and safety of ixazomib plus lenalidomide and dexamethasone following injectable pi‑based therapy in relapsed/refractory multiple myeloma

Detalles Bibliográficos
Autores principales: Abe, Yu, Sasaki, Makoto, Takezako, Naoki, Ito, Shigeki, Suzuki, Kazuhito, Handa, Hiroshi, Chou, Takaaki, Yoshida, Takahiro, Mori, Ikuo, Shinozaki, Tomohiro, Suzuki, Kenshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444673/
https://www.ncbi.nlm.nih.gov/pubmed/37432416
http://dx.doi.org/10.1007/s00277-023-05355-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444673/
https://www.ncbi.nlm.nih.gov/pubmed/37432416
http://dx.doi.org/10.1007/s00277-023-05355-7

Ejemplares similares